Partner Content Partner Content Registration Opens for SMi’s 9th Annual Orphan Drugs & Rare ... Registration Opens for Orphan Drugs
News Akeso's ivonescimab extends survival in PD-L1+ lung cancer Akeso's PD-1xVEGF drug ivonescimab improves survival in another late-stage Chinese trial, ahead of a key international study readout later this year.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
